| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7d10731737e4bbad6867c122e84830b4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_44e578d74c0d8b6abbc31e3817b457ed
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_11e4a8db701c7366c5d00c665249959e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9c76c8c7ac43b89a44e61c85bb46e68a |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P19-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-252 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-465 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-252
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7028
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7034
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P19-56 |
| filingDate |
1999-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8af206f0f9f3e534bc2d3e826c18803a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_452c0274161dc03a2535c27a2b48ef22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f0a4623537bec02127296055990d94af |
| publicationDate |
1999-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-9958544-A1 |
| titleOfInvention |
Hybrid anthracyclines from genetically engineered streptomyces galilaeus strains |
| abstract |
The present invention relates to novel hybrid anthracyclines generated by cloning of fused genes in a mutated Streptomyces galilaeus strain DSM 11638. Said strain was obtained by mutagenization of the S. galilaeus wild type (ATCC 31615). The aglycone moieties of the compounds obtained are modified aklavinones, caused by the gene products introduced into the mutant, and the sugar moieties are those derived from the host strain, i.e. rhodosamine-2-deoxyfucose-2-deoxyfucose or 2-deoxyfucose-2-deoxyfucose-2-deoxyfucose, or the disaccharide or monosaccharide forms of these. |
| priorityDate |
1998-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |